Nicethamide solution for injection 250 mg/ml, 2 ml; Formoterol, Glycopyrronium Bromide and Budesonide, pressurized inhalation, suspension 5/7.2/160 mcg, 120 doses

This tender from KNP "Chornoostrivska Hospital of the Chornoostrivska Village Council" is for the procurement of essential pharmaceutical products. The primary items include Nicethamide solution for injection (250 mg/ml, 2 ml) and a combination inhalation therapy product containing Formoterol, Glycopyrronium Bromide, and Budesonide. The latter is specified as a pressurized inhalation suspension with a dosage of 5/7.2/160 mcg per dose, delivered in a container with 120 doses. The classification according to the Anatomical Therapeutic Chemical (ATC) system for the combination therapy is R03AL11, and its therapeutic area is diseases of the respiratory system. The tender also includes items such as Ethyl Alcohol 70% for external use, and various other medications. The procuring entity, КНП "Чорноострівська лікарня Чорнооострівської селищної ради", is seeking to replenish its medical supplies to ensure the continuity of patient care. The tender details specific packaging, dosage, and quantity requirements for each item, adhering to the conditions of the contract. This procurement is vital for the hospital's ability to provide necessary respiratory treatments and general medical care to its patients.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals, Medical Equipment and Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 7,000.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.